NanoVibronix Files 10-Q for Q2 2025

TL;DR

NanoVibronix 10-Q filed for Q2 2025. Financials and stock details updated.

AI Summary

NanoVibronix, Inc. filed its 10-Q for the period ending June 30, 2025. The filing details financial performance and operational updates for the second quarter. Key financial data and disclosures relevant to investors are presented, including information on preferred stock and common stock.

Why It Matters

This filing provides investors with the latest financial health and operational status of NanoVibronix, Inc., crucial for understanding its performance and future prospects.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information which can reveal risks and opportunities, but the filing itself doesn't introduce new risks.

Key Numbers

• 20250630 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
• 20250819 — Filing Date (The date NanoVibronix, Inc. submitted this 10-Q to the SEC.)

Key Players & Entities

• NanoVibronix, Inc. (company) — Filer of the 10-Q report
• 20250630 (date) — End of the reporting period
• 20250819 (date) — Date the report was filed
• SeriesCPreferredStockMember (stock) — Type of preferred stock mentioned
• SeriesXPreferredStockMember (stock) — Type of preferred stock mentioned
• SeriesGPreferredStockMember (stock) — Type of preferred stock mentioned

FAQ

Key Financial Figures

• $0.001 — ch registered Common stock, par value $0.001 per share NAOV NASDAQ Capital Mark

Filing Documents

• form10-q.htm (10-Q) — 1329KB
• ex31-1.htm (EX-31.1) — 18KB
• ex31-2.htm (EX-31.2) — 10KB
• ex32-1.htm (EX-32.1) — 4KB
• ex32-2.htm (EX-32.2) — 6KB
• 0001641172-25-024854.txt ( ) — 6554KB
• naov-20250630.xsd (EX-101.SCH) — 47KB
• naov-20250630_cal.xml (EX-101.CAL) — 59KB
• naov-20250630_def.xml (EX-101.DEF) — 241KB
• naov-20250630_lab.xml (EX-101.LAB) — 375KB
• naov-20250630_pre.xml (EX-101.PRE) — 322KB
• form10-q_htm.xml (XML) — 893KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited) 1 Condensed Consolidated Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024 1 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2025 and 2024 2 Unaudited Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended June 30, 2025 and 2024 3 Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 4 Notes to Unaudited Condensed Consolidated Financial Statements 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 32 Item 4.

Controls and Procedures

Controls and Procedures 33

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 34 Item 1A.

Risk Factors

Risk Factors 34 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 37 Item 3. Defaults Upon Senior Securities 37 Item 4. Mine Safety Disclosures 37 Item 5. Other Information 37 Item 6. Exhibits 38

Signatures

Signatures 39 i PART I - FINANCIAL INFORMATION ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NanoVibronix, Inc. Condensed Consolidated Balance Sheets (Unaudited) (Amounts in thousands except share and per share data) June 30, 2025 December 31, 2024 (Unaudited) ASSETS: Current assets: Cash and cash equivalents $ 4,030 $ 752 Restricted cash 30 - Trade receivables 115 98 Prepaid expenses and other accounts receivable 511 290 Inventory 2,206 2,191 Total current assets 6,892 3,331 Noncurrent assets: Property and equipment, net 112 9 Severance pay fund 186 173 Operating lease right-of-use assets 145 116 Intangible Assets 5,516 - Goodwill 38,631 - Total non-current assets 44,590 298 Total assets $ 51,482 $ 3,629 LIABILITIES AND STOCKHOLDERS' EQUITY: Current liabilities: Trade payables $ 270 $ 47 Other accounts payable and accrued expenses 4,217 2,608 Loans 1,975 - Deferred revenue - 15 Operating lease liabilities, current 81 52 Total current liabilities 6,543 2,722 Non-current liabilities: Warrant liability 4,161 - Accrued severance pay 232 216 Operating lease liabilities, non-current 69 64 Total liabilities 11,005 3,002 Commitments and contingencies - Stockholders' equity (*): Series G Preferred stock of $ 0.001 par value - Authorized: 400,000 and 0 shares at June 30, 2025 and December 31, 2024, respectively; Issued and outstanding: 633 and 0 shares at June 30, 2025 and December 31, 2024 - (*) - (*) Series X Preferred stock of $ 0.001 par value - Authorized: 62,220 and 0 shares at June 30, 2025, and December 31, 2024, respectively; Issued and outstanding: 6,135 shares at June 30, 2025, and 0 shares at December 31, 2024, respectively - - Preferred stock value (*) - - Common stock of $ 0.001 par value - Authorized: 40,000,000 shares at June 30, 2025, and December 31, 2024, respectively; Issued and outstanding: 787,359 and

View Full Filing

View this 10-Q filing on SEC EDGAR